万家医药量化选股混合发起式C(020492)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-381,546.05 |
2,628,207.86 |
1,966,366.89 |
-468,072.19 |
| 利息合计 |
1,867.08 |
3,429.69 |
1,348.36 |
3,145.52 |
| 其中:存款利息收入 |
1,867.08 |
3,429.69 |
1,348.36 |
3,145.52 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-138,766.03 |
2,673,842.02 |
875,355.41 |
380,354.30 |
| 其中:股票投资收益 |
-277,034.21 |
2,408,022.56 |
703,366.23 |
239,848.54 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
1,224.02 |
1,132.71 |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
138,268.18 |
264,595.44 |
170,856.47 |
140,505.76 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-261,204.11 |
-110,920.10 |
1,076,058.92 |
-859,201.48 |
| 其他收入 |
16,557.01 |
61,856.25 |
13,604.20 |
7,629.47 |
| 费用 |
118,795.96 |
234,972.20 |
101,059.44 |
158,037.11 |
| 管理人报酬 |
85,494.84 |
169,506.02 |
73,016.24 |
109,023.22 |
| 基金托管费 |
14,249.13 |
28,251.09 |
12,169.39 |
18,170.55 |
| 销售服务费 |
18,853.99 |
36,813.09 |
15,657.81 |
23,146.84 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
198.00 |
402.00 |
216.00 |
7,696.50 |
| 利润总额 |
-500,342.01 |
2,393,235.66 |
1,865,307.45 |
-626,109.30 |